HCWB - HCW Biologics GAAP EPS of -$0.15 misses by $0.01 revenue of $1.3M
2023-03-28 16:53:57 ET
- HCW Biologics press release ( NASDAQ: HCWB ): Q4 GAAP EPS of -$0.15 misses by $0.01 .
- Revenue of $1.3M.
- As of December 31, 2022, the Company held $22.3 million in cash and cash equivalents,
For further details see:
HCW Biologics GAAP EPS of -$0.15 misses by $0.01, revenue of $1.3M